NU SKIN ENTERPRISES INC - A (NUS) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:NUS - US67018T1051 - Common Stock
11.02 USD
+0.39 (+3.67%)
11.02 USD
0 (0%)
NUS gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 36 industry peers in the Personal Care Products industry. NUS has an excellent financial health rating, but there are some minor concerns on its profitability. NUS is valued quite cheap, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
- In the past year NUS was profitable.
- NUS had a positive operating cash flow in the past year.
- NUS had positive earnings in 4 of the past 5 years.
- In the past 5 years NUS always reported a positive cash flow from operatings.
1.2 Ratios
- Looking at the Return On Assets, with a value of 7.69%, NUS is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
- NUS has a Return On Equity of 13.70%. This is amongst the best in the industry. NUS outperforms 80.56% of its industry peers.
- NUS has a Return On Invested Capital (4.08%) which is comparable to the rest of the industry.
- The Average Return On Invested Capital over the past 3 years for NUS is significantly below the industry average of 11.83%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.69% | ||
| ROE | 13.7% | ||
| ROIC | 4.08% |
ROA(3y)-1.25%
ROA(5y)2.75%
ROE(3y)-3.26%
ROE(5y)5.55%
ROIC(3y)5.22%
ROIC(5y)9.29%
1.3 Margins
- The Profit Margin of NUS (7.02%) is better than 75.00% of its industry peers.
- With a Operating Margin value of 3.87%, NUS perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
- In the last couple of years the Operating Margin of NUS has declined.
- Looking at the Gross Margin, with a value of 67.20%, NUS is in line with its industry, outperforming 52.78% of the companies in the same industry.
- NUS's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.87% | ||
| PM (TTM) | 7.02% | ||
| GM | 67.2% |
OM growth 3Y-34.86%
OM growth 5Y-23.31%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y-2.13%
2. Health
2.1 Basic Checks
- NUS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- Compared to 1 year ago, NUS has more shares outstanding
- The number of shares outstanding for NUS has been reduced compared to 5 years ago.
- The debt/assets ratio for NUS has been reduced compared to a year ago.
2.2 Solvency
- An Altman-Z score of 3.80 indicates that NUS is not in any danger for bankruptcy at the moment.
- NUS has a Altman-Z score of 3.80. This is in the better half of the industry: NUS outperforms 77.78% of its industry peers.
- The Debt to FCF ratio of NUS is 4.29, which is a neutral value as it means it would take NUS, 4.29 years of fcf income to pay off all of its debts.
- With an excellent Debt to FCF ratio value of 4.29, NUS belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
- NUS has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
- NUS has a Debt to Equity ratio of 0.26. This is in the better half of the industry: NUS outperforms 61.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | 4.29 | ||
| Altman-Z | 3.8 |
ROIC/WACC0.49
WACC8.36%
2.3 Liquidity
- NUS has a Current Ratio of 2.15. This indicates that NUS is financially healthy and has no problem in meeting its short term obligations.
- Looking at the Current ratio, with a value of 2.15, NUS is in line with its industry, outperforming 50.00% of the companies in the same industry.
- A Quick Ratio of 1.45 indicates that NUS should not have too much problems paying its short term obligations.
- The Quick ratio of NUS (1.45) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.15 | ||
| Quick Ratio | 1.45 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 64.29% over the past year.
- The earnings per share for NUS have been decreasing by -22.85% on average. This is quite bad
- The Revenue for NUS has decreased by -12.10% in the past year. This is quite bad
- The Revenue has been decreasing by -6.47% on average over the past years.
EPS 1Y (TTM)64.29%
EPS 3Y-41.01%
EPS 5Y-22.85%
EPS Q2Q%100%
Revenue 1Y (TTM)-12.1%
Revenue growth 3Y-13.71%
Revenue growth 5Y-6.47%
Sales Q2Q%-15.33%
3.2 Future
- NUS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.90% yearly.
- NUS is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -5.77% yearly.
EPS Next Y54.47%
EPS Next 2Y29.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-13.05%
Revenue Next 2Y-5.77%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 7.99, which indicates a rather cheap valuation of NUS.
- Based on the Price/Earnings ratio, NUS is valued cheaply inside the industry as 88.89% of the companies are valued more expensively.
- When comparing the Price/Earnings ratio of NUS to the average of the S&P500 Index (27.30), we can say NUS is valued rather cheaply.
- Based on the Price/Forward Earnings ratio of 7.68, the valuation of NUS can be described as very cheap.
- Based on the Price/Forward Earnings ratio, NUS is valued cheaply inside the industry as 88.89% of the companies are valued more expensively.
- When comparing the Price/Forward Earnings ratio of NUS to the average of the S&P500 Index (24.04), we can say NUS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.99 | ||
| Fwd PE | 7.68 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, NUS is valued cheaply inside the industry as 94.44% of the companies are valued more expensively.
- Based on the Price/Free Cash Flow ratio, NUS is valued cheaply inside the industry as 88.89% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.07 | ||
| EV/EBITDA | 4.24 |
4.3 Compensation for Growth
- NUS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- NUS's earnings are expected to grow with 29.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.15
PEG (5Y)N/A
EPS Next 2Y29.9%
EPS Next 3YN/A
5. Dividend
5.1 Amount
- With a Yearly Dividend Yield of 2.33%, NUS has a reasonable but not impressive dividend return.
- Compared to an average industry Dividend Yield of 2.04, NUS pays a bit more dividend than its industry peers.
- NUS's Dividend Yield is a higher than the S&P500 average which is at 1.92.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.33% |
5.2 History
- The dividend of NUS decreases each year by -30.50%.
- NUS has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-30.5%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- 10.87% of the earnings are spent on dividend by NUS. This is a low number and sustainable payout ratio.
DP10.87%
EPS Next 2Y29.9%
EPS Next 3YN/A
11.02
+0.39 (+3.67%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)02-11 2026-02-11/amc
Inst Owners77.1%
Inst Owner Change0.27%
Ins Owners2.11%
Ins Owner Change-1.5%
Market Cap537.23M
Revenue(TTM)1.56B
Net Income(TTM)109.61M
Analysts45
Price TargetN/A
Short Float %4.83%
Short Ratio5.08
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.33% |
Yearly Dividend0.24
Dividend Growth(5Y)-30.5%
DP10.87%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)42.99%
Min EPS beat(2)12.21%
Max EPS beat(2)73.77%
EPS beat(4)4
Avg EPS beat(4)59.11%
Min EPS beat(4)12.21%
Max EPS beat(4)76.64%
EPS beat(8)7
Avg EPS beat(8)43.78%
EPS beat(12)10
Avg EPS beat(12)34.6%
EPS beat(16)13
Avg EPS beat(16)24.83%
Revenue beat(2)1
Avg Revenue beat(2)-1.07%
Min Revenue beat(2)-3.63%
Max Revenue beat(2)1.5%
Revenue beat(4)3
Avg Revenue beat(4)0.39%
Min Revenue beat(4)-3.63%
Max Revenue beat(4)2.51%
Revenue beat(8)5
Avg Revenue beat(8)-0.35%
Revenue beat(12)5
Avg Revenue beat(12)-1.28%
Revenue beat(16)7
Avg Revenue beat(16)-1.32%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-9.09%
EPS NY rev (1m)0%
EPS NY rev (3m)3.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.4%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.24%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.99 | ||
| Fwd PE | 7.68 | ||
| P/S | 0.34 | ||
| P/FCF | 10.07 | ||
| P/OCF | 6.01 | ||
| P/B | 0.67 | ||
| P/tB | 0.8 | ||
| EV/EBITDA | 4.24 |
EPS(TTM)1.38
EY12.52%
EPS(NY)1.43
Fwd EY13.01%
FCF(TTM)1.09
FCFY9.93%
OCF(TTM)1.83
OCFY16.65%
SpS32.01
BVpS16.41
TBVpS13.78
PEG (NY)0.15
PEG (5Y)N/A
Graham Number22.57
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.69% | ||
| ROE | 13.7% | ||
| ROCE | 5.16% | ||
| ROIC | 4.08% | ||
| ROICexc | 5.21% | ||
| ROICexgc | 6.05% | ||
| OM | 3.87% | ||
| PM (TTM) | 7.02% | ||
| GM | 67.2% | ||
| FCFM | 3.42% |
ROA(3y)-1.25%
ROA(5y)2.75%
ROE(3y)-3.26%
ROE(5y)5.55%
ROIC(3y)5.22%
ROIC(5y)9.29%
ROICexc(3y)6.41%
ROICexc(5y)12.52%
ROICexgc(3y)8.32%
ROICexgc(5y)17.24%
ROCE(3y)6.61%
ROCE(5y)11.76%
ROICexgc growth 3Y-45.58%
ROICexgc growth 5Y-28.67%
ROICexc growth 3Y-42.83%
ROICexc growth 5Y-26.9%
OM growth 3Y-34.86%
OM growth 5Y-23.31%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y-2.13%
F-Score6
Asset Turnover1.1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | 4.29 | ||
| Debt/EBITDA | 1.8 | ||
| Cap/Depr | 64.7% | ||
| Cap/Sales | 2.31% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 76.96% | ||
| Profit Quality | 48.67% | ||
| Current Ratio | 2.15 | ||
| Quick Ratio | 1.45 | ||
| Altman-Z | 3.8 |
F-Score6
WACC8.36%
ROIC/WACC0.49
Cap/Depr(3y)74.52%
Cap/Depr(5y)79.94%
Cap/Sales(3y)2.68%
Cap/Sales(5y)2.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)64.29%
EPS 3Y-41.01%
EPS 5Y-22.85%
EPS Q2Q%100%
EPS Next Y54.47%
EPS Next 2Y29.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.1%
Revenue growth 3Y-13.71%
Revenue growth 5Y-6.47%
Sales Q2Q%-15.33%
Revenue Next Year-13.05%
Revenue Next 2Y-5.77%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-28.1%
EBIT growth 3Y-43.79%
EBIT growth 5Y-28.27%
EBIT Next Year155.65%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y39.66%
FCF growth 3Y-1.31%
FCF growth 5Y-8.9%
OCF growth 1Y-0.72%
OCF growth 3Y-7.59%
OCF growth 5Y-8.88%
NU SKIN ENTERPRISES INC - A / NUS FAQ
Can you provide the ChartMill fundamental rating for NU SKIN ENTERPRISES INC - A?
ChartMill assigns a fundamental rating of 5 / 10 to NUS.
What is the valuation status of NU SKIN ENTERPRISES INC - A (NUS) stock?
ChartMill assigns a valuation rating of 9 / 10 to NU SKIN ENTERPRISES INC - A (NUS). This can be considered as Undervalued.
How profitable is NU SKIN ENTERPRISES INC - A (NUS) stock?
NU SKIN ENTERPRISES INC - A (NUS) has a profitability rating of 4 / 10.
Can you provide the PE and PB ratios for NUS stock?
The Price/Earnings (PE) ratio for NU SKIN ENTERPRISES INC - A (NUS) is 7.99 and the Price/Book (PB) ratio is 0.67.
Can you provide the dividend sustainability for NUS stock?
The dividend rating of NU SKIN ENTERPRISES INC - A (NUS) is 5 / 10 and the dividend payout ratio is 10.87%.